Results 151 to 160 of about 345,692 (191)
Zapalenia płuc w immunosupresji - ogólne problemy kliniczne [PDF]
, 2010 Radzikowska, Elżbieta
core +1 more source
Some of the next articles are maybe not open access.
MS Report, 2023
W XXI w. nastąpił przełom w leczeniu wielu chorób nowotworowych, autoimmunologicznych oraz przewlekłych stanów zapalnych dzięki wprowadzeniu do schematów terapeutycznych przeciwciał monoklonalnych.
M. Piasecki
semanticscholar +1 more source
W XXI w. nastąpił przełom w leczeniu wielu chorób nowotworowych, autoimmunologicznych oraz przewlekłych stanów zapalnych dzięki wprowadzeniu do schematów terapeutycznych przeciwciał monoklonalnych.
M. Piasecki
semanticscholar +1 more source
Revista Paulista de Reumatologia, 2021
O fator de necrose tumoral (TNF), descrito inicialmente na década de 1970, é um dos alvos de atuação molecular que mais atraiu a atenção nas últimas décadas. Durante a década de 1980, foi demonstrado o papel do TNF na etiopatogenia das doenças inflamatórias e estudos iniciais demonstraram uma concentração elevada dessa citocina no líquido sinovial e no
openaire +2 more sources
O fator de necrose tumoral (TNF), descrito inicialmente na década de 1970, é um dos alvos de atuação molecular que mais atraiu a atenção nas últimas décadas. Durante a década de 1980, foi demonstrado o papel do TNF na etiopatogenia das doenças inflamatórias e estudos iniciais demonstraram uma concentração elevada dessa citocina no líquido sinovial e no
openaire +2 more sources
Best Practice & Research Clinical Rheumatology, 2011
There are now five anti-tumour necrosis factor (TNF) drugs licenced for use in rheumatoid arthritis. This chapter examines the similarities and differences between the drugs and looks for clues with regard to their rational prescribing. The major difference is between the monoclonal antibody-based drugs and the soluble receptor etanercept.
Thalayasingam N, Isaacs JD
openaire +3 more sources
There are now five anti-tumour necrosis factor (TNF) drugs licenced for use in rheumatoid arthritis. This chapter examines the similarities and differences between the drugs and looks for clues with regard to their rational prescribing. The major difference is between the monoclonal antibody-based drugs and the soluble receptor etanercept.
Thalayasingam N, Isaacs JD
openaire +3 more sources
Rheumatoid Arthritis — Anti-TNF
International Immunopharmacology, 2015This review will focus on the recent information and strategies now informing best use of TNF inhibitor therapy in RA. These issues include the role of TNFi therapy in early RA management, anti-drug antibodies in TNFi therapy, updates on safety and optimal dosage regimens in long term management.
Khaldoun, Chaabo, Bruce, Kirkham
openaire +2 more sources
Annals of the New York Academy of Sciences, 2006
Abstract: Whenever serum estrogen concentrations are normal in rheumatoid arthritis (RA) patients, lower androgen concentrations (i.e., testosterone, androstenedione, and dehydroepiandrosterone sulfate [DHEAS]) are detected in the serum as well as in the synovial fluid of male and female RA patients.
CUTOLO, MAURIZIO +9 more
openaire +3 more sources
Abstract: Whenever serum estrogen concentrations are normal in rheumatoid arthritis (RA) patients, lower androgen concentrations (i.e., testosterone, androstenedione, and dehydroepiandrosterone sulfate [DHEAS]) are detected in the serum as well as in the synovial fluid of male and female RA patients.
CUTOLO, MAURIZIO +9 more
openaire +3 more sources
TNF-α and IL-6: the link between immune and bone system.
Current Drug Targets, 2020Osteoimmunology is a new subject which focuses on the communication between the immune and the skeletal systems. Both the immune system and bone communicate with each other.
Tiantian Wang, Chengqi He
semanticscholar +1 more source
Anti-TNFs in axial spondyloarthritis
Wiener Medizinische Wochenschrift, 2015Since there is no evidence regarding the efficacy of conventional synthetic disease modifying anti-rheumatic drugs in the improvement of axial spondyloarthritis (SpA), anti-tumor necrosis factors (anti-TNFs) are recommended if nonsteroidal anti-inflammatory drugs fail, or in case of high disease activity.
Roland, Kocijan +2 more
openaire +2 more sources
Sepsis, 1999
Monoclonal antibodies to tumor necrosis factor alpha (TNF-α) and soluble receptor complexes comprising the extramembrane portion of the TNF receptor coupled with the Fc portion of the human IgG1 molecule have been utilized as therapies for severe sepsis and septic shock.
openaire +1 more source
Monoclonal antibodies to tumor necrosis factor alpha (TNF-α) and soluble receptor complexes comprising the extramembrane portion of the TNF receptor coupled with the Fc portion of the human IgG1 molecule have been utilized as therapies for severe sepsis and septic shock.
openaire +1 more source